Lincoln Financial Announces Cash Tender Offer For Certain Outstanding Securities
(i) |
4.375% Senior Notes due 2050 (the “2050 Notes”), |
||
(ii) |
4.350% Senior Notes due 2048 (the “2048 Notes”), |
||
(iii) |
Capital Securities due 2067 (the “2067 Securities”), |
||
(iv) |
Capital Securities due 2066 (the “2066 Securities”), |
||
(v) |
Subordinated Notes due 2067 (the “2067 Subordinated Notes”), |
||
(vi) |
Subordinated Notes due 2066 (collectively with the 2067 Securities, the 2066 Securities and the 2067 Subordinated Notes, the “Subordinated Securities”), |
||
(vii) |
3.050% Senior Notes due 2030 (the “2030 Notes”), and |
||
(viii) |
3.400% Senior Notes due 2032 (the “2032 Notes”). |
The 2050 Notes, the 2048 Notes, the
The following table sets forth certain information regarding the Securities and the Offer:
Title of Security |
CUSIP / ISIN |
Aggregate
|
Sub-Cap
|
Acceptance
|
Fixed Price
|
Reference
|
Bloomberg
|
Fixed
|
Early
|
4.375% Senior Notes due 2050 |
534187 BL2 / US534187BL23
|
|
n/a |
1 |
n/a |
4.625% UST due |
FIT1 |
+120 |
|
4.350% Senior Notes due 2048 |
534187 BG3 / US534187BG38 |
|
n/a |
2 |
n/a |
4.750% UST due |
FIT1 |
+120 |
|
Capital Securities due 2067 |
534187 AU3 / US534187AU31 |
|
|
3 |
|
n/a |
n/a |
n/a |
|
Capital Securities due 2066 |
534187 AS8 / US534187AS84 |
|
4 |
|
n/a |
n/a |
n/a |
|
|
Subordinated Notes due 2067 |
534187 BP3 / US534187BP37 |
|
5 |
|
n/a |
n/a |
n/a |
|
|
Subordinated Notes due 2066 |
534187 BN8 / US534187BN88 |
|
6 |
|
n/a |
n/a |
n/a |
|
|
3.050% Senior Notes due 2030 |
534187 BJ7 / US534187BJ76 |
|
n/a |
7 |
n/a |
3.875% UST due |
FIT1 |
+75 |
|
3.400% Senior Notes due 2032 |
534187 BQ1 / US534187BQ10 |
|
n/a |
8 |
n/a |
4.250% UST due |
FIT1 |
+95 |
|
(1) |
The Sub-Cap represents the maximum aggregate principal amount of the |
|
|
|
|
(2) |
Subject to the Aggregate |
|
|
|
|
(3) |
Includes the Early Tender Premium of |
|
|
|
|
(4) |
The page on Bloomberg from which the lead dealer manager will quote the bid side price of the applicable Reference |
In connection with the Offer, the Company intends to exercise, in full, its issuance right under the Facility Agreement it entered into with
Alongside the Offer, the Company intends to access a new source of contingent liquidity to be provided by means of the contemplated issuance by Belrose Funding Trust II (“Trust II”) of a new series of Pre-Capitalized Trust Securities Redeemable
The Offer will expire at
The consideration paid for Securities that are validly tendered and not validly withdrawn and accepted for purchase pursuant to the Offer will be determined in the manner described in the Offer to Purchase:
(i) |
with respect to each Series of Securities other than the |
|||
|
|
|||
(ii) |
with respect to the |
Holders of Securities that are validly tendered and not validly withdrawn at or prior to
Payment for Securities accepted for purchase will include an amount equal to accrued and unpaid interest thereon from and including their last interest payment date up to, but not including, the applicable settlement date.
The settlement date for Securities that are validly tendered and not validly withdrawn at or prior to the Early Tender Deadline and accepted for purchase is expected to be
Subject to the Aggregate
Securities of the Series in the last Acceptance Priority Level accepted for purchase in accordance with the terms and conditions of the Offer may be subject to proration so that the Company will only accept for purchase Securities resulting in the aggregate purchase price, as calculated pursuant to the Offer to Purchase (excluding accrued interest), not exceeding the Aggregate
Furthermore, (1) if Securities having an aggregate purchase price, as calculated pursuant to the Offer to Purchase (excluding accrued interest), equal to or greater than the Aggregate
The Company’s obligation to accept for purchase, and to pay for, validly tendered Securities that have not been validly withdrawn, if applicable, is subject to, and conditioned upon, satisfaction or, where applicable, waiver of, certain general conditions and a financing condition, in each case as described in the Offer to Purchase.
The financing condition requires (i) the settlement of the issuance and offering of the New P-Caps by Trust II to several initial purchasers and (ii) the settlement and receipt by the Company of the net proceeds from the sale by the Company of the Eligible Assets received as consideration for the sale of the 2.330% Notes due 2030 to Trust I.
The Company reserves the right, in its sole discretion, subject to applicable law, with respect to the Securities to: (i) waive any and all conditions to the Offer with respect to one or more Series of Securities; (ii) extend or terminate the Offer with respect to one or more Series of Securities or change the Acceptance Priority Level with respect to one or more Series of Securities; (iii) increase the Aggregate
Information Relating to the Offer
This press release shall not constitute an offer to sell, a solicitation to subscribe for or purchase, an offer to subscribe for or purchase or a solicitation to sell any securities. The Offer is being made only pursuant to the Offer to Purchase and only in such jurisdictions as is permitted under applicable law.
About Lincoln Financial
Lincoln Financial helps people confidently plan for their vision of a successful financial future. As of
Cautionary Statement Regarding Forward-Looking Statements
Certain statements made in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements. Forward-looking statements may contain words like: “anticipate,” “believe,” “estimate,” “expect,” “project,” “shall,” “will” and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to Trust II’s intent to offer, sell and settle the New P-Caps, the Company’s intent to consummate the exercise of its issuance right under the Facility Agreement with Trust I, issue and deliver the 2.330% Notes due 2030 to Trust I and the Company’s intent to purchase Securities in the Offer, as well as statements related to the Company’s intended use of proceeds from the sale of the Eligible Assets and the expected timing of the actions described herein. The Company claims the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA. Forward-looking statements involve risks and uncertainties. Actual results could differ materially from those expressed in or implied by such forward-looking statements due to a variety of factors, including: Trust II’s ability to consummate the New P-Caps issuance on favorable terms; our ability to consummate the exercise of our issuance right under the Facility Agreement with Trust I and sell the Eligible Assets in a timely manner and on favorable terms, and our ability to satisfy the conditions to the Offer, including the financing condition. The risks and uncertainties included herein are not exhaustive. The Company’s most recent Annual Report on Form 10-K, as well as other reports that the Company files with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20250511774898/en/
Investor Relations
Tina.Madon@LFG.com
Media Relations
Sarah.Boxler@LFG.com
Source: Lincoln Financial